https://www.cafedelabourse.com/archive/article/comment-investir-biotechs

    Cellectis (643 M €)
    Genfit (564 M €)
    Innate Pharma (537 M €)
    Valneva (283 M €)
    Poxel (215 M €)
    Abivax (205 M €)
    Nanobiotix (167 M €)
    Transgene (114 M €)
    Inventiva (104 M €)
    Novacyt (103 M €)
    Erytech Pharma (98 M €)
    Gensight Biologics (90 M €)
    Eurobio Scientific (84 M €)
    Pharnext (76 M €)
    Oncodesign (75 M €)
    Adocia (71 M €)
    GeNeuro (68 M €)
    Ose immunotherapeutics (57 M €)
    Quantum Genomics (51 M €)
    Sensorion (50 M €)
    Lysogene (44 M €)
    Eurofins-Cerep (30 M €)
    GenKyoTex (27 M €)
    Valbiotis (25 M €)
    Predilife (24 M €)
    Hybrigenics (20 M €)
    Plant Advanced Technologies (19 M €)
    Alpha Mos (18 M €)
    Abionyx Pharma (18 M €)
    Genomic Vision (18 M €)
    Theradiag (14 M €)
    GenOway (10 M €)
    Theranexus (10 M €)
    Biophytis (10 M €)
    IntegraGen (9 M €)
    Neovacs (7 M €)
    Noxxon Pharma (7 M €)
